Searched for
INCRED HEALTHCARE PMS
PMS Tracker: Nirmal Bang, Purnartha Investment, Valcreate post gains of up to 11% in FebruaryPortfolio management strategies delivered mixed returns in February, with a few quantitative and multicap portfolios outperforming while se...- PMS Tracker: Quant, fintech strategies lead December gains of up to 8%; Kotak, Aequitas among top performersQuant, fintech and diversified PMS strategies topped December’s charts with gains of up to 8%, even as several small-cap and thematic portf...
- PMS Tracker: Top 15 funds gain over 10% in October; Sundaram, Kotak among biggest gainersAt least 15 PMS funds across small-cap, sectoral and multi-cap themes delivered stellar October returns, led by Sundaram Alternate Assets’ ...
- From Paytm to Eternal: 42 stocks India's top performing PMS fund managers are betting onIndia’s top-performing PMS funds placed bold bets in July across 42 stocks, spanning fintech giants, healthcare disruptors, agrochemicals, ...
- PMS Tracker: Top 15 funds advance up to 14% in July; Maxiom, Kotak among biggest losersIn July 2025, 15 PMS strategies posted gains, led by InCred Asset Management’s Focused Healthcare Portfolio with 14.29%. Smallcap, thematic...
- PMS Tracker FY25: 18 funds gain up to 54%, worst performers shed over 27%PMS strategies: In FY25, 18 PMS strategies posted over 20% gains, with InCred’s Focused Healthcare Portfolio topping at 53.6%. Healthcare a...
- PMS Tracker: Top 10 funds delivered over 48% returns in CY24PMS Funds: Top PMS funds delivered stellar returns in CY2024, with Stallion Asset's Core Fund leading at 69.7%. Thematic strategies in IT, ...
- ETMarkets PMS Talk: Why InCred Healthcare PMS is overweight on hospitals and diagnostics for 2025InCred healthcare portfolio offers a structural investment product that invests in 5 different baskets of businesses like Branded Generics,...
- The year of the HNIs: How India's rich splurged in 2024Indian wealth soared in 2024. Billionaires' net worth increased substantially. Luxury real estate boomed, with significant domestic and int...
- PMS Tracker: Top 10 schemes that helped HNI investors beat the Street in NovemberHigh-net-worth individuals (HNIs) saw impressive returns of up to 8.5% in November through PMS schemes, outperforming the flattish market. ...
- PMS Tracker: HNIs manage to eke out double-digit returns in 2 fundsIn September, at least two PMS schemes significantly outperformed benchmarks, achieving double-digit returns of up to 12%. According to dat...
- How will Biosecure Act impact Indian pharma companies? Aditya Khemka explainsWe own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on th...
- ETMarkets AIF Talk: Fund Manager of Rs 1200 cr AUM reveals 4 key factors for wealth creation in small & midcapsAditya Sood, Fund Manager at InCred Asset Management, discusses small companies' growth potential in an interview with ETMarkets. Sood says...
- Trend of larger, more liquid hospital stocks getting more exorbitantly priced to continue: Aditya KhemkaAditya Khemka of InCred Healthcare PMS discusses the overvaluation of hospital stocks due to liquidity chasing the asset. Liquidity is driv...
- PMS Tracker: These smallcap funds emerged laggards in SeptemberBut in the smallcap category, one of the best-performing funds has been Aequitas Investment’s “India Opportunities”, giving more than 3% re...
- These 15 high-risk PMS equity strategies gave investors upto 73% returns in 1 yearAt least 15 such high-risk PMS strategies have given returns in the range of 40-73% on a 1-year basis, showed data by investment analytics ...
- For next 2-3-years, big alpha can be generated in branded generics and diagnostics: Aditya Khemka“We generally like businesses that generate cash and we have seen lack of cash generation from Western Europe and US businesses. Yes they c...
- Rich using PMS & AIF for alpha generation, MF for beta allocation: Mrinal SinghWe are long-term bottom-up investors and don't try to take a broad-based market call in the near term. In the words of Benjamin Graham "… i...
- Time to invest in pharma funds for a contrarian play?Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an...
- 'Correction a good time to buy large caps'Overseas investors remain in selling mode, but fund managers handling money of the rich are advising investors to deploy cash in select sto...
Load More
